Evaluation of Efficacy and Safety of Lovaza (Omega-3-Acid Ethyl Esters) in Recurrent, Symptomatic Atrial Fibrillation

Clinical trial NCT00402363 · COMPLETED

Trial details

NCT number: NCT00402363
Sponsor: GlaxoSmithKline
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Fibrillation, Atrial

Start date: 2006-11-01
Primary completion: 2010-01-01
Enrollment: 663

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.